USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ascendis Pharma A/S

USPTO PatentsView assignee record - 42 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ascendis ranks #7,661 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 12 technology areas.

#7,661
of 49,997 US assignees by volume
Top 12%
by Innovation Score (51.2/100)
19.5
avg claims per patent
+69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7661 · Foreign Corporation #7,661 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 42 grants
  • UPPER-Q #7,661/49,997
  • PHOTO-FINISH AGC Automotive…
  • CPC-FOCUS A61K · 12 areas
  • INNOV-PAR 51.2/100
  • CLAIMS-RICH 19.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +69% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: AGC Automotive Americas R&D, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ascendis’s 51.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ascendis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ascendis's Innovation Score is 51.2/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ascendis?

Each dot is one of Ascendis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ascendis’s own 19.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ascendis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 41.942.042.04242.042.042.1 0510152025 Granted patents (volume) Avg claims / patent A.M. Surgical, Inc. - 42, 16.5A M SurgicalAGC Automotive Americas R&D, Inc. - 42, 17.71AGC Automotive Am…Allnex Netherlands BV - 42, 17.07Allnex Netherland…ARB Corporation Limited - 42, 5.57ARBAllergan Industrie, SAS - 42, 16.5Allergan Industri…Amtech Systems, LLC - 42, 14.95Amtech SystemsArity International Limited - 42, 18.79Arity Internation…Armaments Research Company, Inc. - 42, 19.26Armaments ResearchAscendis Pharma A/S - 42, 19.5Ascendis Pharma A…
Ascendis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ascendis's grants concentrate

Ascendis Pharma A/S is a focused PatentsView assignee: 12 CPC subclasses with 52.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (6 grants) versus a trough of 1 in 2016. By volume, Ascendis sits between A.M. Surgical, Inc. and Armaments Research Company, Inc..

Ascendis's three-year grant acceleration

Ascendis Pharma A/S shows 15 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ascendis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ascendis holds 42 patents at rank #7,657, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ascendis

By rank, the assignees closest to #7,657 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Ascendis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ascendis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Ascendis ranks #1,019 of 7,163 assignees by patent count in that subclass.

Ascendis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018202020212022202320242025 7
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Ascendis Pharma A/S patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 9.5%
2016 1 2.4%
2017 3 7.1%
2018 5 11.9%
2020 3 7.1%
2021 4 9.5%
2022 5 11.9%
2023 6 14.3%
2024 4 9.5%
2025partial year 7 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ascendis Pharma A/S's patent record in context - here's where to go next.

  • Ascendis Pharma A/S's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 52.4% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #7,661 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ascendis Pharma A/S against A.M. Surgical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 51.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.